Gilead Wins Breach Of Contract Suit Against CDC But Damages, Patent Dispute Are Unresolved

 
• By Brenda Sandburg

Court finds government failed to promptly notify Gilead of its PrEP-related patent applications as required under agreements for supply of HIV drugs used in CDC studies. Whether Gilead will have to license government patents remains undecided.

Breach of contract
Court finds US government breached its agreements with Gilead • Source: Shutterstock

More from Legal & IP

More from Pink Sheet